Do changes in tumor blood flow necessarily lead to changes in tissue oxygenation and in bioenergetic status?
Vaupel
P
P
Institute of Physiology and Pathophysiology, University of Mainz, Germany.
Kelleher
D K
DK
Engel
T
T
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects / Q000502:physiology; D004734:Energy Metabolism / Q000502:physiology*; D006801:Humans; D010101:Oxygen Consumption / Q000502:physiology*; D010725:Phosphocreatine / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000494:pharmacology; D012513:Sarcoma, Experimental / Q000098:blood supply* / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D010725:Phosphocreatine; D000255:Adenosine Triphosphate